560 related articles for article (PubMed ID: 31108968)
1. Melatonin MT
López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
[TBL] [Abstract][Full Text] [Related]
2. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G
Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151
[TBL] [Abstract][Full Text] [Related]
3. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle.
Domínguez-López S; Mahar I; Bambico FR; Labonté B; Ochoa-Sánchez R; Leyton M; Gobbi G
J Psychopharmacol; 2012 Jun; 26(6):830-44. PubMed ID: 21730015
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam.
Ochoa-Sanchez R; Rainer Q; Comai S; Spadoni G; Bedini A; Rivara S; Fraschini F; Mor M; Tarzia G; Gobbi G
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):318-25. PubMed ID: 22789661
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
López-Canul M; Comai S; Domínguez-López S; Granados-Soto V; Gobbi G
Eur J Pharmacol; 2015 Oct; 764():424-432. PubMed ID: 26162699
[TBL] [Abstract][Full Text] [Related]
7. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.
Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT
Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266
[TBL] [Abstract][Full Text] [Related]
8. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Imbesi M; Uz T; Manev H
Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
[TBL] [Abstract][Full Text] [Related]
9. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M
Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258
[TBL] [Abstract][Full Text] [Related]
10. Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways.
Lopez-Canul M; Palazzo E; Dominguez-Lopez S; Luongo L; Lacoste B; Comai S; Angeloni D; Fraschini F; Boccella S; Spadoni G; Bedini A; Tarzia G; Maione S; Granados-Soto V; Gobbi G
Pain; 2015 Feb; 156(2):305-317. PubMed ID: 25599452
[TBL] [Abstract][Full Text] [Related]
11. Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.
Posa L; De Gregorio D; Gobbi G; Comai S
Curr Med Chem; 2018; 25(32):3866-3882. PubMed ID: 28183259
[TBL] [Abstract][Full Text] [Related]
12. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach.
Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M
Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304
[TBL] [Abstract][Full Text] [Related]
13. Melatonin-enhanced hyperactivation of hamster sperm.
Fujinoki M
Reproduction; 2008 Nov; 136(5):533-41. PubMed ID: 18715981
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
15. Melatonin attenuates rat carotid chemoreceptor response to hypercapnic acidosis.
Tjong YW; Chen Y; Liong EC; Ip SF; Tipoe GL; Fung ML
J Pineal Res; 2004 Jan; 36(1):49-57. PubMed ID: 14675130
[TBL] [Abstract][Full Text] [Related]
16. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.
Dubocovich ML; Yun K; Al-Ghoul WM; Benloucif S; Masana MI
FASEB J; 1998 Sep; 12(12):1211-20. PubMed ID: 9737724
[TBL] [Abstract][Full Text] [Related]
17. Nociceptive responses in melatonin MT
Posa L; Lopez-Canul M; Rullo L; De Gregorio D; Dominguez-Lopez S; Kaba Aboud M; Caputi FF; Candeletti S; Romualdi P; Gobbi G
J Pineal Res; 2020 Oct; 69(3):e12671. PubMed ID: 32430930
[TBL] [Abstract][Full Text] [Related]
18. Docking studies for melatonin receptors.
Alkozi HA; Sánchez Montero JM; Doadrio AL; Pintor J
Expert Opin Drug Discov; 2018 Mar; 13(3):241-248. PubMed ID: 29271261
[TBL] [Abstract][Full Text] [Related]
19. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
[TBL] [Abstract][Full Text] [Related]
20. Influence of altered photoperiods on serum melatonin and its receptors (MT1 and MT2) in the brain, retina, and ovary in carp Catla catla.
Moniruzzaman M; Maitra SK
Chronobiol Int; 2012 Mar; 29(2):175-88. PubMed ID: 22324556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
